Table 3. Statistically significant charge differentials in chemotherapy diagnosis-related group, by primary site of cancer.
Mean charges in dollars | Ovary | Lung | Breast | Cervix | Brain | Uterus | Hodgkin's | Myeloid leukemia | Testicle | Melanoma | |
---|---|---|---|---|---|---|---|---|---|---|---|
$1,600 | Ovary | ||||||||||
2,213 | Lung | * | |||||||||
1,759 | Breast | ||||||||||
2,058 | Cervix | ||||||||||
2,414 | Brain | * | |||||||||
2,027 | Uterus | ||||||||||
1,909 | Hodgkin's | ||||||||||
3,361 | Myeloid leukemia | * | * | * | * | * | * | ||||
3,245 | Testicle | * | * | * | * | * | * | * | |||
2,063 | Melanoma | * | * |
Denotes pairs of groups significantly different at the .05 level as determined by the Scheffe multiple range test.